Cigna CI
equity
Price History
Time underwater
How far below its previous all-time high the price sat, each month. 0% means a new high.
Worst drawdown: −78%, peaking May 2007 and bottoming Nov 2008 — 68 months below the prior high before recovering.
DCA Backtest
- Invested
- $50,000
- Value today
- $829,066
- Return
- +1558.1%
- Months invested
- 500
Scenarios
Inflation — the same contributions merely keeping pace with CPI would be $90,910 today, so the real (inflation-adjusted) return is +812.0%.
Lump sum instead — $50,000 all at once in Jan 1985: $2,713,793 (+5327.6%) — lump sum came out ahead.
Worst timing — same monthly amount started at the all-time high (Mar 2024): $2,750 on $3,000 invested (-8.3%).
⚠ Price returns only — dividends are not included. This understates the true return of dividend-paying shares, and any comparison against crypto (which pays no dividends) is biased against equities by roughly the dividend yield, compounded.
If this saved you a spreadsheet — buy me a coffee.
Every start month at once
Each cell is the return-to-date of £/$/€100-a-month DCA started that month. Click a cell to load it in the backtest above. The ringed cell is the all-time-high start — the worst timing scenario.
| J | F | M | A | M | J | J | A | S | O | N | D | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1985 | ||||||||||||
| 1986 | ||||||||||||
| 1987 | ||||||||||||
| 1988 | ||||||||||||
| 1989 | ||||||||||||
| 1990 | ||||||||||||
| 1991 | ||||||||||||
| 1992 | ||||||||||||
| 1993 | ||||||||||||
| 1994 | ||||||||||||
| 1995 | ||||||||||||
| 1996 | ||||||||||||
| 1997 | ||||||||||||
| 1998 | ||||||||||||
| 1999 | ||||||||||||
| 2000 | ||||||||||||
| 2001 | ||||||||||||
| 2002 | ||||||||||||
| 2003 | ||||||||||||
| 2004 | ||||||||||||
| 2005 | ||||||||||||
| 2006 | ||||||||||||
| 2007 | ||||||||||||
| 2008 | ||||||||||||
| 2009 | ||||||||||||
| 2010 | ||||||||||||
| 2011 | ||||||||||||
| 2012 | ||||||||||||
| 2013 | ||||||||||||
| 2014 | ||||||||||||
| 2015 | ||||||||||||
| 2016 | ||||||||||||
| 2017 | ||||||||||||
| 2018 | ||||||||||||
| 2019 | ||||||||||||
| 2020 | ||||||||||||
| 2021 | ||||||||||||
| 2022 | ||||||||||||
| 2023 | ||||||||||||
| 2024 | ||||||||||||
| 2025 | ||||||||||||
| 2026 |
About Cigna
The Cigna Group is an American multinational for-profit managed healthcare and insurance company based in Bloomfield, Connecticut. Cigna's insurance subsidiaries are major providers of medical, dental, disability, life and accident insurance and related products and services, the majority of which are offered through employers and other groups. (Wikipedia)
It's a listed company categorised under health care and health care services, with a market cap of about $73.3B.
It rates High Risk at 2.9/5, meaning several rated factors score badly, so this carries materially more risk than a typical holding.
What pushes the score up: earnings quality (5.0/5) and market / volatility (3.0/5).
Scoring well: liquidity at 1.0/5.
Not yet researched: concentration, governance. These are excluded from the score rather than guessed, so the real risk may be higher than what’s shown.
Ratings summarise sourced facts against fixed rules — not investment advice, and no substitute for your own diligence.
Risk Profile
- Annualised volatility (3yr)3/530.7
- Max drawdown from ATH4/578.3
- Beta vs S&P 5002/50.88
- Avg daily $ volume1/5462.1m
- Float % of shares outstandingnot yet researched
- Debt / equity3/50.75
- Interest coverage (EBIT / interest)2/56.6
- 3yr EPS volatility5/580.1
- Largest customer, % of revenuenot yet researched
- Geographic revenue concentrationnot yet researched
- Board independence %not yet researched
- Share structurenot yet researched
- Litigation / audit historynot yet researched
- Sector regulatory exposure3/5elevated
Linked Assets
Same sector, or return-correlated — worth knowing what else might move if this one does.
- CVS Health CVS+34% (weak)same category: health care, health care services
- Labcorp LH+29% (weak)same category: health care, health care services
- DaVita DVA+23% (weak)same category: health care, health care services
- Quest Diagnostics DGX+23% (weak)same category: health care, health care services
- Elevance Health ELV+54% (moderate)same category: health care
- UnitedHealth Group UNH+43% (moderate)same category: health care
- Solventum SOLV+41% (moderate)same category: health care
- Baxter International BAX+38% (weak)same category: health care